Physician

Bradley Phillip Katz, M. D.

According to 2025 Medicare claims, Bradley Katz, M. D. (NPI: 1891841581) practices pain management in the Montgomery, AL market, with the plurality of this provider's patient population coming from Montgomery, AL. This provider's primary affiliated billing organization is THE CENTER FOR PAIN OF MONTGOMERY LLC (NPI: 1588710289; TIN: 721374394) and primary practice location at 36117-7104.

Katz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 985 traditional Medicare patients, billed 83,619 HCPCS/CPT codes, and received $904,783 in Medicare payments. The top billing code was G0481 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 25,485 prescription claims across 1,930 beneficiaries totaling $970,408 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). 2021 DME data shows 11 claims. Open Payments data shows 93 records totaling $1,651. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,780 to $2,982.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,447	32,298	$919,919
2016	1,754	60,184	$1,184,229
2017	1,414	50,173	$942,799
2018	1,456	39,913	$927,176
2019	1,235	24,877	$841,612
2020	1,112	22,989	$793,002
2021	1,081	23,139	$865,222
2022	963	28,535	$767,677
2023	844	18,216	$839,947
2024	985	83,619	$904,783

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,037	8,505	$613,192
2016	1,259	10,666	$617,069
2017	1,352	12,670	$706,864
2018	1,493	14,239	$806,446
2019	1,362	14,932	$844,649
2020	1,434	17,311	$776,835
2021	1,502	18,777	$827,560
2022	1,558	19,783	$873,634
2023	1,683	22,789	$958,284
2024	1,930	25,485	$970,408

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	15	$1,030
2020	N/R	N/R	N/R
2021	N/R	11	$105
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	460	854	$153
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	646	2,600	$87
80307	Testing for presence of drug, by chemistry analyzers	540	1,122	$56
J2250	Injection, midazolam hydrochloride, per 1 mg	410	2,686	$0
J1010	Injection, methylprednisolone acetate, 1 mg	454	64,898	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	3,907	113,781	$95,851
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	4,955	135,429	$89,596
Xtampza Er	Oxycodone Myristate	143	4,259	$77,733
Belbuca	Buprenorphine Hcl	101	2,970	$72,010
Nucynta Er	Tapentadol Hcl	50	1,500	$54,298

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	93	$1,651	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bradley Phillip Katz, M. D.?

Tedicare shows public-source Medicare data for Bradley Phillip Katz, M. D. (NPI 1891841581), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bradley Phillip Katz, M. D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bradley Phillip Katz, M. D.?

Bradley Phillip Katz, M. D. is linked to THE CENTER FOR PAIN OF MONTGOMERY LLC (billing NPI 1588710289) in the available physician profile data.

Does Bradley Phillip Katz, M. D. have Open Payments data?

Bradley Phillip Katz, M. D. has 93 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.